Cargando…

The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1

Accumulating evidence demonstrates that long non-coding RNA (lncRNA) sprouty4-intron transcript 1 (lncRNA SPRY4-IT1) plays a vital role in the development of breast cancer. However, the underlying mechanism has not been eventually illuminated. We aimed to explore the biological activity of lncRNA SP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Haihua, Wang, Yueyue, Chen, Tiantian, Li, Yu, Wang, Haifeng, Zhang, Lingyu, Chen, Sulian, Wang, Wenrui, Yang, Qingling, Chen, Changjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200706/ https://www.ncbi.nlm.nih.gov/pubmed/30104400 http://dx.doi.org/10.1042/BSR20180411

Ejemplares similares

N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma
por: Yang, Qingling, et al.
Publicado: (2017)

NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018)

The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor
por: Lüttichau, Hans R
Publicado: (2008)

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
por: Wang, Wenrui, et al.
Publicado: (2017)

Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells
por: Wang, Wenrui, et al.
Publicado: (2017)

Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer
por: Wang, Wenrui, et al.
Publicado: (2018)

Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro
por: Li, Shiyu, et al.
Publicado: (2021)

In Vivo Inhibition of CC and CX(3)C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II
por: Chen, Shizhong, et al.
Publicado: (1998)

The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8
por: Endres, Michael J., et al.
Publicado: (1999)

The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors
por: Yamin, Rachel, et al.
Publicado: (2013)

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
por: Wang, Rui, et al.
Publicado: (2015)

Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo
por: Zhang, Shiwen, et al.
Publicado: (2023)

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
por: Wu, Qiong, et al.
Publicado: (2013)

LncRNA SPRY4‑IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro
por: Sang, Weicong, et al.
Publicado: (2023)

LncRNA SPRY4‐IT1 facilitates cell proliferation and angiogenesis of glioma via the miR‐101‐3p/EZH2/VEGFA signaling axis
por: Wang, Ji, et al.
Publicado: (2022)

lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC
por: He, Xuezhi, et al.
Publicado: (2019)

Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo
por: Peng, Wei, et al.
Publicado: (2022)

SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2018)

LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
por: Wang, Yirong, et al.
Publicado: (2019)

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
por: Yang, Qingling, et al.
Publicado: (2014)

Immunocytochemical localization of the lens main intrinsic polypeptide (MIP26) in communicating junctions
Publicado: (1982)

Expression of the gene for main intrinsic polypeptide (MIP): separate spatial distributions of MIP and beta-crystallin gene transcripts in rat lens development
Publicado: (1988)

Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
por: Wang, Haihua, et al.
Publicado: (2022)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

LncRNA SPRY4‐IT1 regulates breast cancer cell stemness through competitively binding miR‐6882‐3p with TCF7L2
por: Song, Xinyue, et al.
Publicado: (2019)

Immunocytochemical localization of the main intrinsic polypeptide (MIP) in ultrathin frozen sections of rat lens
Publicado: (1983)

LncRNA LINC01535 promotes colorectal cancer development and chemoresistance by sponging miR-761
por: Zhao, Changjie, et al.
Publicado: (2021)

LncRNA SPRY4-IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR-101 activity
por: Yao, Hui, et al.
Publicado: (2019)

Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1α Accumulation via Increased Production of Reactive Oxygen Species
por: Ma, Jia, et al.
Publicado: (2013)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2018)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2022)

lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer
por: Cao, Shuguang, et al.
Publicado: (2019)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021)

STAT3-Induced lncRNA SNHG17 Exerts Oncogenic Effects on Ovarian Cancer through Regulating CDK6
por: Pan, Xuefeng, et al.
Publicado: (2020)

Mr. Spry's Case of Poison
por: Spry, James Hume
Publicado: (1800)

Mr. Spry, on Morbid Anatomy
por: Spry, T. H.
Publicado: (1800)

Mr. Spry's Case of Hernia
por: Spry, James Hume
Publicado: (1801)

Phenotypic Changes of LncRNA Hotair in Non-Small-Cell Lung Cancer and Its Clinical Application
por: Huang, Haihua, et al.
Publicado: (2021)

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
por: Vance, Stephen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_38ik3i2oicvkov3uc075bng7fi